Portland, OR, March 14, 2019 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Digital PCR Market by Technology (Droplet Digital PCR (ddPCR) and BEAMing Digital PCR), Product Type (Digital PCR Equipment, Consumables & Reagents, and Software & Services), Application (Clinical Diagnostics, Research, and Forensics), and End User (Clinical Diagnostic Laboratories, Pharmaceuticals and Biotechnology Industries, and University and Government Organizations): Global Opportunity Analysis and Industry Forecast, 2018–2025.” According to the report, the global digital PCR market generated $318.22 million in 2017 and is expected to reach $1.20 billion by 2025, registering a CAGR of 18.0% from 2018 to 2025.
Increase in prevalence of cancer and infectious diseases, technological advancements, and surge in awareness regarding personalized medicine drive the growth in the market. However, reimbursement issues and high initial cost of digital PCR devices restrain the market growth. On the other hand, increased funding for research and development activities create new pathways in the market.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/654
Droplet digital PCR segment to dominate in terms of revenue by 2025
Droplet digital PCR segment contributed the highest market share in 2017, accounting for more than four-fifths of the total share. This is due to its characteristics of providing a precise measure of DNA molecules through each drop and huge sample partitioning. However, the BEAMing digital PCR segment is expected to register the fastest CAGR of 18.9% during the forecast period, owing to high sensitivity to helps in identification and quantification of specific somatic mutations present in DNA and surge in awareness regarding the benefits of this technology.
Software & services segment to manifest fastest growth by 2025
Software & services segment is expected to register the highest CAGR of 19.9% during the forecast period, owing to the software assists in improving the efficiency of digital PCR data management. However, consumables and reagents segment contributed the highest share in 2017, accounting for more than half of the total market, owing to improvement of performance of the overall assay through creation of standardized workflow to help researchers in various areas such as detection of cancer & infectious diseases, food testing, and forensics.
Leading market players
Leading market players analyzed in the market include Bio-Rad Laboratories, Inc. (RainDance Technologies, Inc.), Qiagen N.V. (Formulatrix, Inc.), JN Medsys, Fluidigm Corporation, Expedeon AG, Sysmex Corporation (Sysmex Inostics GmbH), Stilla Technologies, Merck KGaA, and Thermo Fisher Scientific, Inc.
About Us
Allied Market Research (AMR) is a full-service market research andbusiness-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.